618 related articles for article (PubMed ID: 30103646)
1. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
3. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort.
Chen HH; Chen YM; Chen TJ; Lan JL; Lin CH; Chen DY
Clinics (Sao Paulo); 2011; 66(7):1177-82. PubMed ID: 21876970
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
5. Risk of infective endocarditis in patients with systemic lupus erythematosus in Taiwan: a nationwide population-based study.
Chang YS; Chang CC; Chen YH; Chen WS; Chen JH
Lupus; 2017 Oct; 26(11):1149-1156. PubMed ID: 28420053
[TBL] [Abstract][Full Text] [Related]
6. Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort.
González-Echavarri C; Capdevila O; Espinosa G; Suárez S; Marín-Ballvé A; González-León R; Rodríguez-Carballeira M; Fonseca-Aizpuru E; Pinilla B; Pallarés L; Ruiz-Irastorza G;
Lupus; 2018 Dec; 27(14):2253-2261. PubMed ID: 30451641
[TBL] [Abstract][Full Text] [Related]
7. Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.
Rúa-Figueroa I; López-Longo FJ; Del Campo V; Galindo-Izquierdo M; Uriarte E; Torre-Cisneros J; Vela P; Tomero E; Narváez J; Olivé A; Freire M; Salgado E; Andreu JL; Martínez-Taboada V; Calvo-Alén J; Hernández-Cruz B; Raya E; Quevedo V; Expósito Pérez L; Fernández-Nebro A; Ibañez M; Pascual-Valls È; Rúa-Figueroa D; Naranjo A; Pego-Reigosa JM
J Rheumatol; 2020 Feb; 47(2):234-240. PubMed ID: 30988123
[TBL] [Abstract][Full Text] [Related]
8. Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus.
Kabadi S; Yeaw J; Bacani AK; Tafesse E; Bos K; Karkare S; DeKoven M; Vina ER
Lupus; 2018 Oct; 27(11):1799-1809. PubMed ID: 30068254
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus.
Pryor BD; Bologna SG; Kahl LE
Arthritis Rheum; 1996 Sep; 39(9):1475-82. PubMed ID: 8814058
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study.
Ferreira JC; Marques HH; Ferriani MP; Gormezano NW; Terreri MT; Pereira RM; Magalhães CS; Campos LM; Bugni V; Okuda EM; Marini R; Pileggi GS; Barbosa CM; Bonfá E; Silva CA
Lupus; 2016 Jun; 25(7):754-9. PubMed ID: 26821966
[TBL] [Abstract][Full Text] [Related]
11. Infection in systemic lupus erythematosus.
Janwityanuchit S; Totemchokchyakarn K; Krachangwongchai K; Vatanasuk M
J Med Assoc Thai; 1993 Oct; 76(10):542-8. PubMed ID: 7964223
[TBL] [Abstract][Full Text] [Related]
12. Damage in systemic lupus erythematosus and its association with corticosteroids.
Zonana-Nacach A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
Zamora LD; Collante MTM; Navarra SV
Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
[TBL] [Abstract][Full Text] [Related]
14. Association of herpes zoster infection with clinical characteristics and MBL2 gene polymorphisms in Chinese children with systemic lupus erythematosus.
Wu SA; Yeh KW; Yao TC; Huang JL
Pediatr Infect Dis J; 2011 Aug; 30(8):656-60. PubMed ID: 21343839
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
[TBL] [Abstract][Full Text] [Related]
16. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
Garnier C; Ribes D; Chauveau D; Huart A; Pugnet G; Adoue D; Prevot G; Alric L; Delobel P; Derumeaux H; Mengelle C; Sailler L; Moulis G
J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
[TBL] [Abstract][Full Text] [Related]
17. Risks of interstitial cystitis among patients with systemic lupus erythematosus: A population-based cohort study.
Wen JY; Lo TS; Chuang YC; Ho CH; Long CY; Law KS; Tong YC; Wu MP
Int J Urol; 2019 Sep; 26(9):897-902. PubMed ID: 31311067
[TBL] [Abstract][Full Text] [Related]
18. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.
Desai RJ; Bateman BT; Huybrechts KF; Patorno E; Hernandez-Diaz S; Park Y; Dejene SZ; Cohen J; Mogun H; Kim SC
BMJ; 2017 Mar; 356():j895. PubMed ID: 28264814
[No Abstract] [Full Text] [Related]
19. Risk of systemic lupus erythematosus in patients with human papillomavirus infection: a population-based retrospective cohort study.
Shi LH; Huang JY; Liu YZ; Chiou JY; Wu R; Wei JC
Lupus; 2018 Dec; 27(14):2279-2283. PubMed ID: 30451639
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?
Rascu A; Manger K; Kraetsch HG; Kalden JR; Manger B
Lupus; 1996 Aug; 5(4):323-7. PubMed ID: 8869906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
